Substituted heterocyclic compounds and methods of use
AssigneeAmgen Inc.
InventorsJohn L. Buchanan, Daniel Elbaum, Matthew W. Martin, David C. McGowan, Perry M. Novak, Joseph J. Nunes
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmgen Inc.
InventorsJohn L. Buchanan, Daniel Elbaum, Matthew W. Martin, David C. McGowan, Perry M. Novak, Joseph J. Nunes
Estimating the term…
The present invention relates to pyrimidine or pyridine carbamate compounds having the general Formula I: and pharmaceutically acceptable salts or derivatives thereof. Also included are methods of treatment of various diseases and conditions, including inflammation, inhibition of T cell activation and proliferation, arthritis, organ transplant, ischemic or reperfusion injury, myocardial infarction, stroke, multiple sclerosis, inflammatory bowel disease, Crohn's disease, lupus, hypersensitivity, type 1 diabetes, psoriasis, dermatitis, Hashimoto's thyroiditis, Sjogren's syndrome, autoimmune hyperthyroidism, Addison's disease, autoimmune diseases, glomerulonephritis, allergic diseases, asthma, hayfever, eczema, cancer, colon carcinoma, thymoma, just to name a few, in a mammal, the methods comprising administering a therapeutically-effective amount a compound of Formula I, or a salt or derivative form thereof, as described above.
A compound of Formula I
Dependencies are inferred from the claim text.